| HRN 004- Peginterferon a-2a Plus Ribavirin for Chronic Hepatitis C Infection in HIV Infected Persons Who Have Failed to Achieve a Sustained Virologic Response Following Previous Interferon Therapy (NCT00215839) | Hepatitis Resource Network | |
| The Safety of Zidovudine Plus Interferon-Alpha in HIV-Infected Children (NCT00000967) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Safety and Effectiveness of 524W91 (NCT00002335) | Glaxo Wellcome | |
| A Study of Nevirapine to Prevent HIV Transmission From Mothers to Their Infants (NCT00001135) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of the Safety and Effectiveness of Treating Advanced AIDS Patients Between Ages 4 and 22 With 7 Drugs, Some at Higher Than Usual Doses (NCT00001108) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Zidovudine Plus Interleukin-2 in HIV-Infected Patients Who Have No Symptoms of Infection But Who Have Tender Lymph Nodes (NCT00001005) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Three Different Anti-HIV Drug Combinations in HIV-Infected Patients (NCT00002410) | Dupont Merck | |
| A Study of Treatments for Fungal Infections of the Mouth and Throat in HIV-Infected Patients Who Have Had Success With Itraconazole But Not With Fluconazole (NCT00002341) | Janssen, LP | |
| A Study of Zidovudine in Infants Exposed to the HIV Before or Soon After Birth (NCT00001007) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Comparison of Two Dose Levels of Indinavir Combined With Two Nucleoside Analogue Reverse Transcriptase Inhibitors (NRTIs) in HIV-Infected Patients (NCT00002406) | Merck Sharp & Dohme LLC | |
| Neurodevelopmental and Neurological Study of Infants and Children With HIV-1 Infection and AIDS in Clinical Trials (NCT00000759) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia Derived HIV-1 Recombinant Envelope Glycoprotein (gp160) of Human Immunodeficiency Virus: Evaluation of a 200-mcg Dose (NCT00001056) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Chlorhexidine in the Prevention of HIV-1 Transmission From Mothers to Their Babies (NCT00006075) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study to Compare Two Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Previously Received Anti-HIV Treatment (NCT00004581) | Abbott | |
| Influence of Probenecid and Quinine on the Pharmacokinetics of Azidothymidine (NCT00000706) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Safety and Effectiveness of an Anti-HIV Drug Combination Taken Twice Daily (NCT00002241) | Merck Sharp & Dohme LLC | |
| A Comparison of Two Types of Injected Nutritional Supplements in Patients With AIDS and Pneumocystis Carinii Pneumonia (PCP) (NCT00002275) | Abbott | |
| Anti-HIV Medications and Structured Treatment Interruptions for People Recently Infected With HIV (NCT00084032) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Retrovir in the Treatment of Psoriasis in HIV-Positive Patients (NCT00002286) | Glaxo Wellcome | |
| T-20 With Anti-HIV Combination Therapy for Patients With Prior Anti-HIV Drug Treatment and/or Drug Resistance to Each of the Three Classes of Approved Anti-HIV Drugs (NCT00008528) | Hoffmann-La Roche | |
| A Comparison of SCH 56592 and Fluconazole in the Treatment of Oropharyngeal Candidiasis (OPC) in HIV-Positive Patients (NCT00002399) | Schering-Plough | |
| Effects of MAC Preventive Therapy on Disease-Causing Bacteria in HIV-Infected Patients: A Substudy of CPCRA 048 (NCT00000933) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Active Immunization of HIV-Infected Pregnant Women: A Phase I Study of Safety and Immunogenicity of a rgp120/HIV-1 Vaccine (NOTE: Some Patients Receive Placebo) (NCT00001046) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Safety and Effectiveness of Peridex in Preventing or Delaying Fungal Infections of the Mouth in HIV-Infected Patients (NCT00002431) | Procter and Gamble | |
| Comparison of Brovavir Versus Acyclovir in the Treatment of Herpes in HIV-Infected Patients (NCT00000953) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Methadone Effects on Zidovudine (ZDV, AZT) Disposition (NCT00000800) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Ganciclovir: Compassionate Use in Patients With Serious or Life-Threatening Cytomegalovirus Infections (NCT00002024) | Hoffmann-La Roche | |
| Safety and Immune Response Study of High-Dose Canarypox ALVAC-HIV Vaccine in Healthy, HIV Uninfected Adults (NCT00027261) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Safety and Effectiveness of Ganciclovir in the Prevention of Cytomegalovirus (CMV) of the Eyes and Disease of the Stomach and Intestines in Patients With HIV (NCT00001034) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Toxoplasmic Encephalitis in Patients With AIDS. Treatment and Prevention of Relapse (NCT00002064) | Palo Alto Medical Foundation | |
| Randomized, Double-Blind, Placebo-Controlled Trial of Nimodipine for the Neurological Manifestations of HIV-1 (NCT00000738) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Comparison of Three Different Initial Treatments Without Protease Inhibitors for HIV Infection (NCT00013520) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of ALRT 1057 Topical Gel in Patients With AIDS-Related Kaposi's Sarcoma (NCT00002439) | Anderson Clinical Research | |
| A Study of Pentamidine Plus Dapsone in the Prevention of Pneumocystis Carinii Pneumonia (PCP) in HIV-Infected Patients Who Cannot Take Trimethoprim or Sulfonamides (NCT00001028) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Effects of Home Visits on Medication Adherence in Children and Youth With HIV (NCT00006439) | National Center for Research Resources (NCRR) | |
| A Study of Thalidomide in HIV-Infected Patients Who Are Receiving HAART (NCT00002392) | Rockefeller University | |
| A Study to Test the Safety of Recombinant Interleukin-2 (rIL-2) in HIV-Infected Children (NCT00000849) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Use of Chemotherapy Plus Radiotherapy Plus Azidothymidine in Patients With AIDS-Related Lymph Node Cancer (NCT00000723) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Comparison of Two Methods in the Treatment of Cytomegalovirus of the Eyes in Patients With AIDS (NCT00001061) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Safety and Effects of Giving a New HIV Vaccine (GENEVAX-HIV) to HIV-Negative Volunteers (NCT00002231) | Wyeth-Lederle Vaccines | |
| A Phase I Multicenter Trial to Evaluate the Safety and Immunogenicity of HIV-1 Recombinant Envelope Glycoprotein gp160 (NCT00000757) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Phase II Trial of Sequential Chemotherapy and Radiotherapy for AIDS-Related Primary Central Nervous System Lymphoma (NCT00000801) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Comparison of Two Anti-HIV Treatment Plans (NCT00005915) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study on the Management of Combination Anti-HIV Drug Therapy in HIV-Positive Children With Prior Treatment (NCT00000902) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study to Evaluate the Effect of Cimetidine on CD4 Lymphocyte Counts in HIV Infection (NCT00002092) | Community Research Initiative of New England | |
| A Phase III Comparative Study of Dapsone / Trimethoprim and Clindamycin / Primaquine Versus Sulfamethoxazole / Trimethoprim in the Treatment of Mild-to-Moderate PCP in Patients With AIDS (NCT00000640) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Open, Non-Comparative Study of Fluconazole in Patients With Coccidioidal Meningitis (NCT00002010) | Pfizer | |
| A Study of PMPA in HIV-Infected Patients (NCT00002180) | Gilead Sciences | |
| Safety and Tolerability of Z-100 in Patients With Early HIV Infection (NCT00016692) | Zeria Pharmaceutical | |
| An Escalating Dose Tolerance Trial of BG8962 (rCD4) in Patients Who Are HIV Antibody Positive (NCT00000721) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Double-Blind, Placebo-Controlled Trial of Albendazole in HIV-Positive Patients With Intestinal Microsporidiosis (NCT00002191) | SmithKline Beecham | |
| Observing Patients With Early HIV Infection (NCT00005020) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| CMV Retinitis Retreatment Trial (NCT00000766) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase III Randomized, Double-Blind, Controlled Study of the Use of Anti-HIV Immune Serum Globulin (HIVIG) for the Prevention of Maternal-Fetal HIV Transmission in Pregnant Women and Newborns Receiving Zidovudine (AZT) (NCT00000751) | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | |
| Adding New Drugs for HIV Infected Patients Failing Current Therapy (NCT00031044) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Safety and Effectiveness of Indinavir Sulfate Plus Efavirenz (NCT00002387) | Merck Sharp & Dohme LLC | |
| Interleukin-2 (IL-2), Pegylated Interferon (PEG-IFN Alfa-2b), and Ribavirin (RBV) Treatment in Patients With Hepatitis C and HIV Coinfection (NCT00015652) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of AZT in HIV-Infected Patients With AIDS-Related Kaposi's Sarcoma (NCT00000994) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| An Open Label Study to Evaluate the Long-Term Safety and Effectiveness of Aerosol Pentamidine in the Prophylaxis of Pneumocystis Carinii Pneumonia in AIDS Patients (NCT00002030) | Fisons | |
| The Safety of Tenofovir Disoproxil Fumarate Taken With Other Anti-HIV Drugs to Treat HIV-Infected Patients (NCT00007436) | Gilead Sciences | |
| Discontinuation of Antiretroviral Therapy in Patients With Asymptomatic HIV Infection (NCT00050284) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Randomized, Controlled, Multicenter Trial of Filgrastim (Recombinant-Methionyl Human Granulocyte Colony Stimulating Factor; G-CSF) for the Prevention of Grade 4 Neutropenia in Patients With HIV Infection. (NCT00002126) | Amgen | |
| An Open Label Evaluation of the Safety and Pharmacokinetics of Ganciclovir in Children (NCT00002015) | Roche Global Development | |
| A Randomized, Double-Blind Phase II/III Trial of Monotherapy vs. Combination Therapy With Nucleoside Analogs in HIV-Infected Persons With CD4 Cells of 200-500/mm3 (NCT00000625) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Phase I Trial of mBACOD and Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in AIDS-Associated Large Cell, Immunoblastic, and Small Non-cleaved Lymphoma (NCT00000689) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Disease Progression and Anti-HIV Treatments (NCT00001068) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| An Investigational Combination Vaccine Given to People Who Are Not Infected With HIV (NCT00027365) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Pilot Pharmacokinetic Phase I Evaluation of BI-RG-587 in HIV-Infected Children (NCT00000634) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Randomized, Placebo-Controlled, Double-Blinded Phase I Safety and Immunogenicity Trial of Recombinant Envelope Protein, HIV-1 SF-2 rgp120 (BIOCINE), Combined With MF59 in HIV-1 Uninfected Adult Volunteers (NCT00000832) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Effectiveness and Safety of Epivir/Ziagen/Zerit (3TC/ABC/d4T) Versus Epivir/Ziagen/Sustiva (3TC/ABC/EFV) Versus Epivir/Ziagen/Agenerase/Norvir (3TC/ABC/APV/RTV) in HIV Patients Who Have Never Received Treatment (NCT00005017) | Glaxo Wellcome | |
| A Study of Fluconazole in the Treatment of Fungal Infections of the Throat in Patients With Weakened Immune Systems (NCT00002339) | Pfizer | |
| A Comparison of ISIS 2922 Used Immediately or Later in Patients With Cytomegalovirus (CMV) of the Eyes (NCT00002355) | Ionis Pharmaceuticals, Inc. | |
| A Study of Indinavir Sulfate Given Together With Stavudine to HIV-Positive Patients (NCT00002354) | Merck Sharp & Dohme LLC | |
| Safety and Effectiveness of CPI-1189 in HIV-Infected Males on Combination Anti-HIV Drug Therapy (NCT00002209) | Centaur Pharmaceuticals | |
| A Pilot Randomized, Double-Blind, Placebo-Controlled, Parallel Design, Multicenter Trial to Evaluate the Effect of Ranitidine on Immunologic Indicators in Asymptomatic HIV-1 Infected Subjects With a CD4 Cell Count Between 400-700 Cells/mm3 (NCT00002106) | Glaxo Wellcome | |
| Safety and Tolerability of a Therapeutic DNA Dendritic Cell Vaccine in HIV-Infected Children, Adolescents, and Young Adults (NCT00614640) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study to Collect Information About HIV-Positive Pregnant Women and Their Babies (NCT00000910) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of AZT Plus Human Interferon Alpha in the Treatment of AIDS-Related Kaposi's Sarcoma (NCT00001113) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Multicenter, Open-Label, Randomized, 24-Week Study to Compare the Safety and Activity of Indinavir Sulfate, 800 Mg q 8 h Versus 1,200 Mg q 12 h in Combination With Zidovudine and 3TC (NCT00002208) | Merck Sharp & Dohme LLC | |
| The Safety and Effectiveness of Hydroxyurea and ddI Used Individually or Together in HIV-Infected Patients (NCT00001074) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Safety and Effectiveness of Adefovir Dipivoxil Plus Indinavir Combined With Zidovudine or Lamivudine or Stavudine in HIV-Infected Patients Who Have Not Taken Anti-HIV Drugs (NCT00002379) | Gilead Sciences | |
| A Phase I Study of Methotrexate for HIV Infection (NCT00000834) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Multicenter Dose Ranging Clinical Trial of 2',3'-Dideoxycytidine in the Treatment of Patients With AIDS and Advanced ARC. (NCT00000704) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Estimating the Incidence of HIV Infection Among Men Who Have Sex With Men in Peru and Ecuador (NCT00279331) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Comparison of Three Treatments for Pneumocystis Pneumonia in AIDS Patients (NCT00000730) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Dose-Escalating Study of Ro 31-8959 ( HIV Protease Inhibitor ) in Patients With HIV Disease. (NCT00002111) | Stanford University | |
| Use of Stealth Liposomal Doxorubicin HCl ( DOX-SL ) in the Treatment of Moderate to Severe AIDS-Related Kaposi's Sarcoma. (NCT00002147) | Sequus Pharmaceuticals | |
| The Effectiveness of Indinavir Plus Zidovudine Plus Lamivudine in HIV-Infected Patients With No Symptoms of Infection (NCT00002179) | Merck Sharp & Dohme LLC | |
| A Study on the Effect of High-Calorie Infant Formula on Growth and Nutrition in HIV-Infected Infants (NCT00000873) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Comparison of Zidovudine Plus Lamivudine Versus ddI Used Alone or in Combination With Zidovudine in HIV-1 Infected Children (NCT00001066) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of AL721 in HIV-Infected Patients With Swollen Lymph Nodes (NCT00001012) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Nitazoxanide in Patients With AIDS and Diarrhea Caused by Cryptosporidium (NCT00001081) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I Study of TNP-470 in the Treatment of AIDS-Associated Kaposi's Sarcoma (NCT00000763) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| ABT-378/Ritonavir and Efavirenz in HIV-Infected Patients Who Have Taken More Than One Protease Inhibitor in the Past (NCT00004582) | ViRx | |
| The Role of Naive T-Cells in HIV Pathogenesis (NCT00206531) | Bayside Health | |
| Safety of and Immune Response to an HIV Vaccine (SF-2 gp120) With or Without MTP-PE/MF59 Adjuvant (NCT00001019) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Treatment of Patients With Human Immunodeficiency Virus (HIV)-Related Chronic Diarrhea With Saccharomyces Boulardii or Placebo: A Double Blind Trial (NCT00002088) | Biocodex | |
| The Effects of Illnesses on HIV Levels in the Body (NCT00000900) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Dextran Sulfate in HIV-Infected Patients and in Patients With AIDS or AIDS Related Complex (ARC) (NCT00001009) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of a Combination of Four Drugs in Patients With Recent HIV Infection (NCT00002233) | Glaxo Wellcome | |